Sign In
Buy DOCS
$21.04
-0.470 (-2.19%)
At Close: Jun 03, 2026
Doximity: Digital Health Play With Strong Fundamentals
05:16am, Wednesday, 21'st Jun 2023
Doximity's recent Investor Day showcased platform enhancements and long-term financial targets, including achieving $1 billion in revenue and adjusted EBITDA margins of 45% or higher by FY28. The comp
More Likely to 5x First: Doximity vs. Walgreens
06:00am, Wednesday, 14'th Jun 2023
Doximity delivers double-digit growth -- and some of the biggest healthcare players are clients. Walgreens has invested in growing in the trillion-dollar primary care market.
2 Growing Healthcare Stocks to Own for the Long Term
07:30am, Tuesday, 13'th Jun 2023
Intuitive Surgical has been running higher on optimism that margins will rebound sooner than later. Doximity just shared its five-year goals, which could prove a profitable journey for shareholders.
2 Magnificent Growth Stocks to Buy With $100 Right Now
05:29am, Friday, 09'th Jun 2023
Making smaller, more frequent stock purchases is an easy way for everyday investors to avoid heavy, unexpected losses. SoFi Technologies is a member-focused digital bank that keeps growing by leaps an
2 Soaring Healthcare Stocks That Could Climb Even Higher
06:27am, Monday, 05'th Jun 2023
Shares of Veeva Systems and Doximity surged during the week ended June 2 and they're probably not finished climbing. Veeva Systems is a software-as-a-service company that caters to the biopharmaceutic
3 Things Investors Will Love About Doximity (and 1 They Won't)
09:30am, Friday, 02'nd Jun 2023
Doximity's networking platform is popular with healthcare professionals. That has made it easy for advertisers to target the healthcare industry.
Better Healthcare AI Stock: Moderna vs. Doximity
05:30am, Friday, 02'nd Jun 2023
Moderna hopes AI will make drug discovery faster and more precise. Doximity is using AI to help doctors save time.
Dr Martens tumbles as City puts boot in after margin warning
04:17am, Thursday, 01'st Jun 2023
Dr Martens PLC (LSE:DOCS) shares tumbled 11% in early exchanges as the company warned of lower margins in the year ahead alongside a 26% decline in annual pre-tax profit. The City put the boot as the
Dr Martens PLC profit tumbles, margins seen lower in year ahead
02:28am, Thursday, 01'st Jun 2023
Dr Martens PLC (LSE:DOCS) revenue topped the £1bn mark for the first time but it couldn't prevent the iconic bootmaker reporting a heavy fall in profit. The FTSE 250 company posted revenue in the yea
Dr Martens tumbles 6% as RBC sticks the boot in
06:51am, Tuesday, 30'th May 2023
Dr Martens PLC (LSE:DOCS) tumbled 6.2% as broker RBC Capital Markets put the boot in ahead of the iconic shoemaker's full year results on Thursday. Shares fell to 151.30p as the broker downgraded the
1 No-Brainer Stock to Buy With $100 Right Now
09:30am, Sunday, 28'th May 2023
Doximity's productivity-boosting platform is used by over 80% of U.S. physicians and 90% of graduates. This large segment provides a lucrative advertising environment for drugmakers and hospitals.
Doximity (DOCS) Reports Q4 Earnings: What Key Metrics Have to Say
06:06pm, Friday, 26'th May 2023
Although the revenue and EPS for Doximity (DOCS) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street
Doximity to Present at the William Blair 43rd Annual Growth Stock Conference
04:15pm, Tuesday, 23'rd May 2023
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Dr. Nate Gross, co-founder and chief strategy officer, wi
Doximity is an Overlooked Medical Ecosystem AI Play
08:11am, Tuesday, 23'rd May 2023
Doximity Inc. NASDAQ: DOCS is a digital professional social network platform for medical practitioners. It's a medical community networking platform like a Microsoft Co. NASDAQ: MSFT owned LinkedIn th
2 Growth Stocks Billionaires Keep Buying Hand Over Fist
05:11am, Thursday, 18'th May 2023
Studying the activity of billionaire investors is one way to jump-start your stock-picking process. Steven Cohen's Point72 fund made a big bet on Doximity, a social media platform for physicians, in t
